Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003232359 | SCV001645491 | likely benign | Sotos syndrome | 2022-08-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002368366 | SCV002663780 | likely benign | Inborn genetic diseases | 2020-07-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV003232359 | SCV002794758 | likely benign | Sotos syndrome | 2022-02-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004751983 | SCV005344396 | likely benign | NSD1-related disorder | 2022-12-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |